Elite Pharmaceuticals, Inc. Liabilities, Noncurrent
Elite Pharmaceuticals, Inc. (ELTP) had Liabilities, Noncurrent of $4.40 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Noncurrent $4.40M.
- 2026-03-31: Liabilities, Noncurrent $22.02M.
- 2025-12-31: Liabilities, Noncurrent $32.91M.
- 2025-09-30: Liabilities, Noncurrent $44.99M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $4.40M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $22.02M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $32.91M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $44.99M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $52.89M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $31.03M 10-K · filed 2026-06-29 | |
| 2024-12-31 | $39.62M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $28.08M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $15.58M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $13.02M 10-K · filed 2025-06-30 | |
| 2023-12-31 | $9.12M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $6.55M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.30M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.10M 10-K · filed 2024-07-01 | |
| 2022-12-31 | $15.89M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $16.31M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $15.50M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.23M 10-K · filed 2023-06-29 | |
| 2021-12-31 | $3.28M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $3.82M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.50M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $4.23M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $4.79M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $5.98M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $7.40M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $5.66M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $7.26M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $5.52M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.63M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.10M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $5.80M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $6.28M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $6.83M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.29M 10-K · filed 2019-06-21 | |
| 2017-12-31 | $7.44M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $8.27M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $12.69M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $5.30M 10-K · filed 2018-06-14 | |
| 2016-12-31 | $5.47M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $7.26M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.14M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $15.87M 10-K · filed 2017-06-14 | $16.06M 10-K · filed 2016-06-15 |
| 2015-12-31 | $23.84M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $15.36M 10-Q · filed 2015-12-30 | $11.70M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $17.22M 10-Q · filed 2015-12-30 | $41.87M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $20.58M 10-K · filed 2016-06-15 | $55.58M 10-K · filed 2015-06-15 |
| 2014-12-31 | $51.89M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $75.45M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $101.11M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $99.36M 10-K · filed 2015-06-15 | |
| 2013-12-31 | $10.70M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $11.54M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $11.48M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $14.44M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $17.34M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $27.11M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $28.78M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $20.75M 10-K · filed 2013-06-21 | |
| 2011-12-31 | $19.94M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $30.05M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $45.71M 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | $24.99M 10-K · filed 2012-06-29 |